Andra språk AbbVie Inc.

Aktier

ABBV

US00287Y1091

Farmaceutiska produkter

Marknaden stängd - Nyse Andra börsplatser 22.01.28 2026-05-12			5-dagars förändring	Förändring 1 jan.
207,86 ^USD	+2,51 %		+0,85 %	−9,03 %

05-09	Irlands finanspolitiska framgång riskerar att leda till ett överförtroende
05-05	AbbVie Inc. presenterar nya långtidsdata för Skyrizi och Rinvoq vid inflammatorisk tarmsjukdom	CI

Andra språk

05-12	Het Ierse fiscale succes versus het risico op afhankelijkheid
05-12	Il successo fiscale irlandese di fronte al rischio di dipendenza
05-11	Novo Nordisk to Sell Parkinson's Cell Therapy to Startup Cellular Intelligence
05-11	Irlands Steuererfolg und das Risiko der Abhängigkeit
05-11	El éxito fiscal de Irlanda frente al riesgo de dependencia
05-11	Morning Meeting: Same old story
05-09	Ireland's fiscal success faces the risk of over-reliance
05-08	Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth, Maintains Full-Year 2026 Financial Guidance
05-06	AbbVie to Present at the Bank of America Securities Healthcare Conference
05-06	Morning Meeting: Anleger sind echte Chip-Jäger
05-05	AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®
05-05	AbbVie Inc. Presents New Long-Term Data For Skyrizi And Rinvoq In Inflammatory Bowel Diseases
05-04	Weight-loss revolution sparks new appetite for aesthetics firms
05-04	Global pharma companies that have publicly announced Trump drug pricing agreements
05-04	Kyverna Therapeutics, Inc. Appoints Nadia Dac as Chief Commercial Officer, Effective May 4, 2026
05-04	SKYRIZI® (risankizumab) Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis
05-04	Abbvie Announces Skyrizi (Risankizumab) Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis
05-04	Tenax Therapeutics, Inc. Appoints Timothy Healey as Chief Commercial Officer, Effective May 4, 2026
05-01	Big Pharma M&A set for mega year as patent expiries drive deal urgency
04-30	AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
04-30	AbbVie Expected to Post Durable Growth Into Mid-2030s, BofA Securities Says
04-30	Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month
04-30	MORNING BRIEFING - USA/Asien
04-30	MORNING BRIEFING - Deutschland/Europa -2-
04-29	MÄRKTE USA/Wall Street wenig verändert - Zwischen Fed-Entscheid und Tech-Zahlen